aspirin

Generic: aspirin

Labeler: h-e-b
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler h-e-b
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
H-E-B

Identifiers & Regulatory

Product NDC 37808-174
Product ID 37808-174_1a4adc09-11db-4342-e063-6294a90ade8d
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2024-07-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 37808174
Hyphenated Format 37808-174

Supplemental Identifiers

RxCUI
198467
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 300 TABLET, COATED in 1 BOTTLE (37808-174-32)
  • 500 TABLET, COATED in 1 BOTTLE (37808-174-53)
  • 100 TABLET, COATED in 1 BOTTLE (37808-174-73)
source: ndc

Packages (3)

37808-174-32 300 TABLET, COATED in 1 BOTTLE (37808-174-32) 37808-174-53 500 TABLET, COATED in 1 BOTTLE (37808-174-53) 37808-174-73 100 TABLET, COATED in 1 BOTTLE (37808-174-73)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

ASPIRIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1a4adc09-11db-4342-e063-6294a90ade8d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["085b35db-62e4-38db-e063-6394a90a9763"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["H-E-B"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "300 TABLET, COATED in 1 BOTTLE (37808-174-32)", "package_ndc": "37808-174-32", "marketing_start_date": "20240701"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE (37808-174-53)", "package_ndc": "37808-174-53", "marketing_start_date": "20240701"}, {"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE (37808-174-73)", "package_ndc": "37808-174-73", "marketing_start_date": "20240701"}], "brand_name": "ASPIRIN", "product_id": "37808-174_1a4adc09-11db-4342-e063-6294a90ade8d", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "37808-174", "generic_name": "ASPIRIN", "labeler_name": "H-E-B", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240701", "listing_expiration_date": "20261231"}